This site doesn't support Internet Explorer. Please use a modern browser like Chrome, Firefox or Edge.
About the Program
CME program with the aim of giving access to the physicians to the latest updates in science in haemato-oncology disease area and its treatment.
▪ The agenda features a mix of clinical updates and lively debates on challenging scientific topics impacting the field, such as biosimilars value in hematologic malignancies, follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.
▪ 3 Scientific Societies | 6 Scientific Sessions| CME Credits| Local and International Speakers Board